Orthodontic Band affixed with Glass Ionomer Cement for Caries Detector

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Caries Detector+3 More
Orthodontic Band affixed with Glass Ionomer Cement - Device
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether putting orthodontic bands with cement on teeth can help prevent or reverse cavities, compared to just monitoring teeth without intervention.

Eligible Conditions
  • Caries Detector
  • Dental caries
  • Surface-Active Agents

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Caries Detector

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 months from previous recall visit

Month 6
Radiographic Assessment of Interproximal Carious lesions

Trial Safety

Safety Progress

1 of 3

Other trials for Caries Detector

Trial Design

2 Treatment Groups

Non-banded Tooth
1 of 2
Banded Tooth
1 of 2
Active Control
Experimental Treatment

38 Total Participants · 2 Treatment Groups

Primary Treatment: Orthodontic Band affixed with Glass Ionomer Cement · No Placebo Group · N/A

Banded Tooth
Device
Experimental Group · 1 Intervention: Orthodontic Band affixed with Glass Ionomer Cement · Intervention Types: Device
Non-banded ToothNoIntervention Group · 1 Intervention: Non-banded Tooth · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months from previous recall visit

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
554 Previous Clinical Trials
1,152,134 Total Patients Enrolled
Macaire C Thiel, DDS MSPrincipal InvestigatorChildren's Hospital of Wisconsin, Pediatric Dental Residency Program Faculty

Eligibility Criteria

Age < 18 · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are healthy.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 30th, 2021

Last Reviewed: October 31st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.